Speech-Language Pathologists in Dillon, SC Accepting Medicare
7 Speech-Language Pathologists found. Showing 1 - 7
 Amber Brittney Meekins, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1221 David St, Dillon, SC 29536 Phone: 843-845-2588 |
Mrs. Alicia M Davis, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 408 S 16th Ave, Dillon, SC 29536 Phone: 843-774-7128 Fax: 843-774-5205 |
 Therapy Solutions Of Dillon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 N Macarthur Ave, Dillon, SC 29536 Phone: 843-774-7462 |
April Mcduffie Grainger, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 N Macarthur Ave, Dillon, SC 29536 Phone: 843-774-7462 Fax: 843-841-2482 |
Tinaya Alexis Mcrae Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 138 Legion Dr, Dillon, SC 29536 Phone: 843-245-0618 |
Mrs. Shirley Chappell Mace, MEA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 East Jackson St, Mcleod Medical Center Dillon, Dillon, SC 29536 Phone: 843-774-1536 Fax: 843-841-3302 |
He Says She Says Speech Language Therapy Services, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1311 Tyler Rd, Dillon, SC 29536 Phone: 803-614-1898 Fax: 843-841-3100 |
News Archive
U.S. DOE awards Verenium additional $4.9M for development of cellulosic ethanol biorefinery plants
Verenium Corporation, a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that it has been awarded an additional $4.9 million from the U.S. Department of Energy (DOE) to fund ongoing activities at its demonstration-scale facility in Jennings, Louisiana.
New wiring diagram shows how brain organizes information
University of Utah (U of U) medical researchers have uncovered a wiring diagram that shows how the brain pays attention to visual, cognitive, sensory, and motor cues. The research provides a critical foundation for the study of abnormalities in attention that can be seen in many brain disorders such as autism, schizophrenia, and attention deficit disorder.
Notum gene plays a key role in planarian's regeneration decision-making process
A seldom-studied gene known as notum plays a key role in the planarian's regeneration decision-making process, according to Whitehead Institute scientists. Protein from this gene determines whether a head or tail will regrow at appropriate amputation sites.
Keryx Biopharmaceuticals reports net loss of $4.7M for 2009 fourth quarter
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease (the "Company"), today announced its results for the fourth quarter and year ended December 31, 2009.
New mechanism may explain neurons shrinking in Huntington's disease
A hallmark of neurodegenerative diseases like Huntington's is the progressive death of nerve cells in the brain. The cells don't die quickly, though. They first start to disconnect from each other because their neurites - long finger-like extensions that make connections all through the brain - become smaller.
› Verified 8 days ago
Chiropractors
Speech-Language Pathologists
Optometrists
Physical Therapists
Occupational Therapists